Assessing and managing breast cancer risk: Clinicians' current practice and future needs
Open Access
- 1 October 2014
- journal article
- Published by Elsevier in The Breast
- Vol. 23 (5) , 644-650
Abstract
No abstract availableKeywords
Funding Information
- Australia and New Zealand Breast Cancer Trials Group
- National Breast Cancer Foundation Practitioner Fellowship
This publication has 24 references indexed in Scilit:
- Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialThe Lancet, 2014
- Decision aids for people facing health treatment or screening decisions2014
- Preventing breast and ovarian cancers in high‐risk BRCA1 and BRCA2 mutation carriersMedical Journal of Australia, 2013
- Exemestane for Breast-Cancer Prevention in Postmenopausal WomenNew England Journal of Medicine, 2011
- Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningBritish Journal of Cancer, 2011
- Patient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-AnalysisJournal of Clinical Oncology, 2010
- Assessing Women at High Risk of Breast Cancer: A Review of Risk Assessment ModelsJNCI: Journal of the National Cancer Institute, 2010
- Implementing, Embedding, and Integrating Practices: An Outline of Normalization Process TheorySociology, 2009
- Developing a quality criteria framework for patient decision aids: online international Delphi consensus processBMJ, 2006
- ABC of breast diseases: Breast cancer---epidemiology, risk factors, and geneticsBMJ, 2000